GLP-1 receptor agonists such as semaglutide and tirzepatide are FDA-regulated for chronic weight management in adults with a BMI of 30 or higher, or 27 with a weight-related condition. Las Vegas runs around the clock, and dealers, servers, performers and resort staff working overnight and rotating shifts rarely fit a daytime clinic into their week - even as the job keeps appearance and stamina front of mind. Telehealth works on their clock: a licensed Nevada physician reviews your online assessment under Nevada Revised Statutes §629.515, and compounded medication from an FDA-registered 503B pharmacy ships to your Las Vegas address. Monthly cost runs $199–$379 versus about $1,247 for brand-name Ozempic or Wegovy. Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Serving Las Vegas ZIP codes: 89101, 89102, 89104, 89109, 89119.
Local clinics serving Michael Way: Premier Physicians Weight Loss & Wellness, Medical Reducing Inc and We Do Care Weight Loss. Many patients compare these in-person options against licensed GLP-1 telehealth — prescribed online, shipped to the door.
Tirzepatide seen from Michael Way, without the jargon. In head-to-head comparisons, tirzepatide has posted some of the highest average weight-loss numbers ever measured for a non-surgical treatment.
Each dose increase is a key moment: that is often when side effects briefly return. This gradual schedule aims to limit nausea and find the minimum effective dose rather than climbing as fast as possible.
On the cost side, expect about $250-600/month compounded via telehealth; about $1,000-1,400/month brand-name without insurance. In this state, Nevada Revised Statutes §629.515; the reference body is Nevada State Board of Medical Examiners. For a Michael Way resident, Tirzepatide is now largely managed remotely, home delivery included. Typical dosing: 2.5 - 5 - 7.5 - 10 - 12.5 - 15 mg/week, stepped up by tolerance and goal.
In the SURMOUNT head-to-head trials, tirzepatide produced greater average weight loss, likely thanks to its dual GIP + GLP-1 action. Response is individual and should be assessed by a physician.
Depending on the timing, you resume as soon as possible or wait for the next injection; the clinician adapts, and you never double up without advice.
Yes: both are tirzepatide. Mounjaro is dosed/labeled for type 2 diabetes, Zepbound for weight management.
Medical Director: Dr. Steven Nguyen, MD, Board-Certified Internal Medicine. Licensed in Nevada. All prescriptions issued under Nevada Revised Statutes §629.515 and supervised by Nevada State Board of Medical Examiners.